128 related articles for article (PubMed ID: 21122052)
21. Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis.
Paul A; Kranz G; Schindl A; Kranz GS; Auff E; Sycha T
Lasers Surg Med; 2010 Mar; 42(3):211-4. PubMed ID: 20333738
[TBL] [Abstract][Full Text] [Related]
22. Blue-colored sweating: four infants with apocrine chromhidrosis.
Yöntem A; Kör D; Hızlı-Karabacak B; Karakaş M; Önenli-Mungan N
Turk J Pediatr; 2015; 57(3):290-3. PubMed ID: 26701951
[TBL] [Abstract][Full Text] [Related]
23. [Chromhidrosis with green sweat. A case report presented as a problem of occupational medicine].
Berg O; Gyntelberg F
Ugeskr Laeger; 1981 Jun; 143(25):1620-1. PubMed ID: 7303200
[No Abstract] [Full Text] [Related]
24. [Botulinum toxin for the treatment of secretory disorders of the head and neck area].
Steffen A
HNO; 2012 Jun; 60(6):484-9. PubMed ID: 22669436
[TBL] [Abstract][Full Text] [Related]
25. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis.
Kreyden OP; Scheidegger EP
Clin Dermatol; 2004; 22(1):40-4. PubMed ID: 15158544
[TBL] [Abstract][Full Text] [Related]
26. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
Baş B; Ozan B; Muğlali M; Celebi N
Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718
[TBL] [Abstract][Full Text] [Related]
27. Treatment of apocrine chromhidrosis with topical capsaicin.
Marks JG
J Am Acad Dermatol; 1989 Aug; 21(2 Pt 2):418-20. PubMed ID: 2474015
[TBL] [Abstract][Full Text] [Related]
28. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
Vadoud-Seyedi J; Simonart T
Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
[TBL] [Abstract][Full Text] [Related]
29. Eccrine Chromhidrosis in an Adolescent with Sickle Cell Disease.
Park JG; Prose NS; Garza R
Pediatr Dermatol; 2017 Sep; 34(5):e273-e274. PubMed ID: 28758317
[TBL] [Abstract][Full Text] [Related]
30. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
Solish N; Benohanian A; Kowalski JW;
Dermatol Surg; 2005 Apr; 31(4):405-13. PubMed ID: 15871315
[TBL] [Abstract][Full Text] [Related]
31. Multiple eccrine hidrocystomas--from diagnosis to treatment: the role of dermatoscopy and botulinum toxin.
Correia O; Duarte AF; Barros AM; Rocha N
Dermatology; 2009; 219(1):77-9. PubMed ID: 19420900
[TBL] [Abstract][Full Text] [Related]
32. Experience with botulinum toxin type A in medically intractable pediatric chronic daily headache.
Ahmed K; Oas KH; Mack KJ; Garza I
Pediatr Neurol; 2010 Nov; 43(5):316-9. PubMed ID: 20933173
[TBL] [Abstract][Full Text] [Related]
33. Selective sweat gland removal with minimal skin excision in the treatment of axillary hyperhidrosis: a retrospective clinical and histological review of 15 patients.
Lawrence CM; Lonsdale Eccles AA
Br J Dermatol; 2006 Jul; 155(1):115-8. PubMed ID: 16792762
[TBL] [Abstract][Full Text] [Related]
34. Pseudochromhidrosis: report and review of literature.
Tempark T; Wittayakornrerk S; Jirasukprasert L; Chatproedprai S; Wananukul S
Int J Dermatol; 2017 May; 56(5):496-502. PubMed ID: 28233291
[TBL] [Abstract][Full Text] [Related]
35. Chromhidrosis: An Unusual Cause of Skin Discoloration.
Suessman A; Srinivasan S
Pediatr Emerg Care; 2021 Dec; 37(12):e875-e876. PubMed ID: 30964853
[TBL] [Abstract][Full Text] [Related]
36. [INTRACORNEAL ECCRINE PSEUDO-CHROMHIDROSIS].
DEGOS R; CIVATTE J
Bull Soc Fr Dermatol Syphiligr; 1963; 70():402-3. PubMed ID: 14079075
[No Abstract] [Full Text] [Related]
37. Axillary injection of botulinum A toxin in a patient with muscle cramps associated with severe axillary hyperhidrosis.
Filosto M; Bertolasi L; Fincati E; Priori A; Tomelleri G; Chieregato G; Rizzuto N
Acta Neurol Belg; 2001 Jun; 101(2):121-3. PubMed ID: 11486559
[TBL] [Abstract][Full Text] [Related]
38. Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease.
Kulaksizoglu H; Parman Y
Parkinsonism Relat Disord; 2010 Sep; 16(8):531-4. PubMed ID: 20637678
[TBL] [Abstract][Full Text] [Related]
39. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M
Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
